NYXH.BR - NYXOAH
€8.90 0.24 (2.77%)
Updated: 08:21 May 8, 2024 ESTNext Session's AI Forecast
95.72%
Avg. Accuracy (AI)
€8.61
Next Week's AI Forecast
100%
Trend's Accuracy (AI)
€8.41
| Rank (0-100) |
| Rank (0-100) |
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | -1.99 | -1.07 | -0.5 | 0.57 | 0.09 |
|---|
CURRENT VOLATILITY RANK
Variation from the lowest to the highest value in a period.
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 3.59 | 5.07 | 5.12 | 5.5 | 3.65 |
|---|
STOCHASTIC METRIC
The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.
| Curr. Week | Next Week | Curr. Month | Curr. Quarter | 0% | 0% | 0% | 0% |
|---|
MOVING AVERAGE METRIC
| 5 Sessions | Change 5 Sessions | 20 Sessions | Change 20 Sessions | 50 Sessions | Change 50 Sessions | 200 Sessions | 8.66 | -7.87% | 9.4 | -9.18% | 10.35 | 25.3% | 8.26 |
|---|
RSI METRIC
| RS Hour | RSI Hour | RS Day | RSI Day | 0.74 | 33.33 | 0.86 | 42.53 |
|---|
NYXOAH Technical Analysis News
NYXOAH
Rue Edouard Belin 12
Mont-Saint-Guibert 1435
Belgium
32 10 22 23 55
https://www.nyxoah.com
| Sectors: | Healthcare |
| Industry: | Medical Instruments & Supplies |
| F. Time Employees: | 146 |
Description
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Corporate Governance
Nyxoah S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
List of holders with stock participation in NYXOAH.
| Holder Rank | Holder | Shares | Date Reported | % Out | Value |
|---|